SPECTRAL AI, INC. Research and Development Expense
SPECTRAL AI, INC. (MDAI) reported Research and Development Expense of $1.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-11
- SPECTRAL AI, INC. research and development expense for the quarter ending 2026-06-30 was $1.70M, a 16.40% increase year-over-year.
- SPECTRAL AI, INC. research and development expense for the quarter ending 2026-03-31 was $2.00M, a 44.44% decline year-over-year.
- SPECTRAL AI, INC. research and development expense for the quarter ending 2025-09-30 was $6.23M.
- SPECTRAL AI, INC. research and development expense for the quarter ending 2025-06-30 was $1.46M.
- SPECTRAL AI, INC. research and development expense for fiscal 2023 was $15.10M, a 8.48% decline from fiscal 2022.
- SPECTRAL AI, INC. research and development expense for fiscal 2022 was $16.50M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.70M 10-Q · filed 2026-08-11 | $3.26M 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | $2.00M 10-Q · filed 2026-05-13 | ||||
| 2025-09-30 | $6.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $7.69M derived: sum of 2 quarters · filed 2026-08-11 | $9.00M 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $1.46M 10-Q · filed 2026-08-11 | $2.77M 10-Q · filed 2026-08-11 | $6.60M 10-Q · filed 2025-08-13 | ||
| 2025-03-31 | $3.60M 10-Q · filed 2026-05-13 | ||||
| 2024-09-30 | $14.90M 10-Q · filed 2025-11-13 | ||||
| 2024-03-31 | $4.30M 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $15.10M 10-K · filed 2024-03-29 | ||||
| 2023-03-31 | $4.00M 10-Q · filed 2024-05-09 | ||||
| 2022-12-31 | $16.50M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |